David M. Hockenbery

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Area:
Cell Biology, Molecular Biology
Google:
"David Hockenbery"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Centini R, Tsang M, Iwata T, et al. (2018) Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation. Plos One. 13: e0197973
Hickson SE, Margineantu D, Hockenbery DM, et al. (2018) Inhibition of vaccinia virus replication by nitazoxanide. Virology. 518: 398-405
Berger S, Procko E, Margineantu D, et al. (2016) Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer. Elife. 5
Reyes NL, Banks GB, Tsang M, et al. (2015) Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 112: 424-9
Procko E, Berguig GY, Shen BW, et al. (2014) A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells. Cell. 157: 1644-56
Park H, Staehling K, Tsang M, et al. (2012) Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity. 36: 769-81
Delgado T, Carroll PA, Punjabi AS, et al. (2010) Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 10696-701
Susnow N, Zeng L, Margineantu D, et al. (2009) Bcl-2 family proteins as regulators of oxidative stress. Seminars in Cancer Biology. 19: 42-9
See more...